SFX by Ex Libris Inc.

Title:	Oncogenic mutations of ALK kinase in neuroblastoma
Source:	Nature [0028-0836] Chen, Y yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	George, R. "Activating mutations in ALK provide a therapeutic target in neuroblastoma." Nature 455.7215 (2008): 975-978.
description	2.	Janoueix-Lerosey, I. "Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma." Nature 455.7215 (2008): 967-970.
description	3.	Spieker, N. "The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32." Genomics 71.2 (2001): 214-21.
description	4.	Caron, H. "Neuroblastoma: biology, prognosis, and treatment." The Pediatric clinics of North America 55.1 (2008): 97-120.
description	5.	MacBeath, Jordan A B. "A quantitative protein interaction network for the ErbB receptors using protein microarrays." Nature 439.7073 (2005): 168-74.
description	6.	Mossé, Andrew M. "Identification of ALK as a major familial neuroblastoma predisposition gene." Nature 455.7215 (2008): 930-935.
description	7.	Sanda, T. "Transcription factors as therapeutic targets in lymphoid malignancies." International reviews of immunology 26.5-6 (2007): 305-332.
description	8.	Park, Julie R. "Neuroblastoma: Biology, Prognosis, and Treatment." Hematology/oncology clinics of North America 24.1 (2010): 65-86.
description	9.	Hagan, N. "Dissecting the protein-RNA and RNA-RNA interactions in the nucleocapsid-mediated dimerization and isomerization of HIV-1 stemloop 1." Journal of molecular biology 365.2 (2007): 396-410.
description	10.	Kaihatsu, K. "Extending recognition by peptide nucleic acids (PNAs): Binding to duplex DNA and inhibition of transcription by tail-clamp PNA-Peptide conjugates." Biochemistry 42.47 (2003): 13996-14003.
description	11.	Longo, Gian Paolo P. "Familial neuroblastoma: a complex heritable disease." Cancer letters 197.1-2 (2003): 41-5.
description	12.	Schleiermacher, G. "Recent insights into the biology of neuroblastoma." International journal of cancer 135.10 (2014): 2249-61.
description	13.	Croce, M. "Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen." Cancer immunology, immunotherapy 57.11 (2008): 1625-1634.
description	14.	Woessmann, A. "Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines." Cancer chemotherapy and pharmacology 50.5: 397-404.
description	15.	Castleberry, Gregory K P. "Changing trends of research and treatment in infant neuroblastoma." Pediatric blood & cancer 49.7, Suppl. S (2008): 1060-5.
description	16.	Castleberry, R P P. "Biology and treatment of neuroblastoma." The Pediatric clinics of North America 44.4 (1997): 919-37.
description	17.	Michalowski, MB B. "Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors." Pediatric blood & cancer 50.1 (2007): 29-32.
description	18.	Albeck, John G G. "Collecting and organizing systematic sets of protein data." Nature reviews. Molecular cell biology 7.11 (2006): 803-812.
description	19.	Stiffler, Michael A A. "Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays." Journal of the American Chemical Society 128.17: 5913-5922.
description	20.	Rohrschneider, Larry R R. "The gift of Gab." FEBS letters 515.1-3 (2002): 1-7.